Unknown

Dataset Information

0

Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade.


ABSTRACT: With the widespread use of programmed death receptor-1 (PD-1) blockade therapy, sensitive and specific predictive biomarkers that guide patient selection are urgently needed. T-cell receptor (TCR) repertoire, which reflects antitumor T-cell responses based on antigen specificity, is expected as a novel biomarker for PD-1 blockade therapy. In the present study, the TCR repertoire of eight patients with gastrointestinal cancer treated with anti-PD-1 antibody (nivolumab) was analyzed. To analyze the tumor-associated T-cell clones in the blood and their mobilization into the tumor, we focused on T-cell clones that presented in both blood and tumor (blood-tumor overlapping clones). Responders to PD-1 blockade tended to exhibit a higher number of overlapping clones in the tumor and a higher total frequency in the blood. Moreover, a higher total frequency of overlapping clones in blood CD8+ T cells before treatment was associated with a favorable clinical response. Collectively, these results suggest the possibility of blood-tumor TCR repertoire overlap to predict clinical response to PD-1 blockade and guide patient selection before the treatment.

SUBMITTER: Aoki H 

PROVIDER: S-EPMC8353913 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-07-13 | GSE154536 | GEO
2021-07-13 | GSE154539 | GEO
2021-07-13 | GSE154538 | GEO
2024-11-26 | GSE267639 | GEO
2024-11-26 | GSE267645 | GEO
| S-EPMC7691446 | biostudies-literature
| PRJNA646627 | ENA
| S-EPMC6020019 | biostudies-literature
2024-11-26 | GSE267642 | GEO
| PRJNA646623 | ENA